US 8,791,270 · Application 13/969,724
US Patent 8,791,270 — assignment history and current owner
Bendamustine Pharmaceutical Compositions
Who owns US Patent 8,791,270?
US8791270 ("Bendamustine Pharmaceutical Compositions") — current assignee: CEPHALON LLC. Status: Expired. 1 recorded USPTO assignment.
Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 8,791,270 is CEPHALON LLC. Based on the most recent name change record (recorded 2022-07-26).
- Patent title
- Bendamustine Pharmaceutical Compositions
- Application number
- 13/969,724
- Apparent operating assignee
- CEPHALON LLC
- Patent status
- Expired
- Recorded assignments
- 1
Recorded assignment history
| Executed | Recorded | Conveyance | Assignor(s) | Assignee(s) | Reel/frame |
|---|---|---|---|---|---|
| Jun 30, 2022 | Jul 26, 2022 | Name Change | CEPHALON, INC. | CEPHALON LLC | 60921/78 |
Scrolls sideways on narrow screens
Chain of title
In 2022, CEPHALON, INC. changed its name to CEPHALON LLC.
Apparent recorded rights summary — disclaimer
This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.
The prosecution record for your AI
Application 13/969,724 · US 8,791,270
Ownership settled? Give your AI the file.
The recorded chain of title is one part of the record. PatentReply compiles the rest of US 8,791,270, from the claims as filed to the last action, for Claude, ChatGPT, Cursor, or another supported AI workspace.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.